Saturn V Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Saturn V Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-31,529	Closed	-$1.05M	–	30
2024 Q3	$1.05M	Sell	31,529 -39,913	-56%	-$1.37M	0.38%	25
2024 Q2	$1.93M	Buy	+71,442	New	+$1.41M	0.73%	23

Saturn V Capital Management's LBPH Position: Q4 2024 in Review

Saturn V Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 31,529 shares — an estimated $1.05M sold.

Saturn V Capital Management first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $1.93M in Q2 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Saturn V Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Saturn V Capital Management sold 31,529 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.05M.
Saturn V Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Saturn V Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.93M in Q2 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Saturn V Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.